Inovio Pharmaceuticals (MEX:INO) Land And Improvements: MXN Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:INO Inovio Pharmaceuticals Inc MEX:INO
52 GF Score
Price MXN21.00
GF Value MXN3.77
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Inovio Pharmaceuticals Land And Improvements?

Inovio Pharmaceuticals MEX:INO 52 Land And Improvements is MXN Mil as of Jun. 2026. GuruFocus rates MEX:INO with a GF Score™ of 52/100 and a GF Value™ of MXN3.77 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Inovio Pharmaceuticals's land and improvements for the quarter that ended in Jun. 2026 was MXN Mil.

Inovio Pharmaceuticals Land And Improvements Historical Data

* Premium members only.

The historical data trend for Inovio Pharmaceuticals's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inovio Pharmaceuticals Land And Improvements Chart

Inovio Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Inovio Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
MEX:INO
52GF Score
Inovio Pharmaceuticals Inc MEX:INO
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inovio Pharmaceuticals Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of MXN Mil mean?
Inovio Pharmaceuticals (MEX:INO) has a Land And Improvements of MXN Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Inovio Pharmaceuticals and its competitors.
Is Inovio Pharmaceuticals' Land And Improvements too high?
Inovio Pharmaceuticals' current Land And Improvements is MXN Mil. Overall, Inovio Pharmaceuticals has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inovio Pharmaceuticals' Land And Improvements compare to HURA and VTVT?
Inovio Pharmaceuticals' Land And Improvements of MXN Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Biotechnology company?
A good Land And Improvements depends on the Biotechnology industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Inovio Pharmaceuticals and its competitors. Inovio Pharmaceuticals's current Land And Improvements is MXN Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inovio Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Inovio Pharmaceuticals (MEX:INO) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN3.77, compared to a current price of MXN21.00 — trading 457% above its estimated fair value. The current Land And Improvements is MXN Mil. Inovio Pharmaceuticals' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Inovio Pharmaceuticals (MEX:INO), the current Land And Improvements is MXN Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inovio Pharmaceuticals (MEX:INO) Overvalued in 2026?

Based on GuruFocus' analysis, Inovio Pharmaceuticals stock appears to be overvalued. The current stock price of MXN21.00 is trading 457% above its estimated GF Value™ of MXN3.77. GuruFocus considers Inovio Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for MEX:INO:

  • Land And Improvements: MXN Mil
  • GF Value™: MXN3.77 vs. price of MXN21.00 (457% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the MEX:INO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inovio Pharmaceuticals Business Description

Other Exchanges INO:USA0A43:UKGBM:Germany
Address 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Plymouth Meeting, Pennsylvania, that develops DNA medicines to treat and prevent diseases. Its core technology uses optimized DNA plasmids delivered via proprietary electroporation devices to prompt cells to produce therapeutic proteins and generate immune responses. The company's pipeline targets HPV-associated diseases, cancers, and infectious diseases. Its lead candidate, INO-3107, is being developed for recurrent respiratory papillomatosis, a rare HPV-driven respiratory condition, and has received orphan drug and breakthrough therapy designations. Other programs include DNA-based immunotherapies for HPV-related cancers and vaccine candidates for infectious diseases. Inovio has historically funded operations through partnerships, grants, and public offerings, and it collaborates with academic institutions, governments, and pharmaceutical companies. It operates primarily in the United States and conducts clinical trials internationally.
52GF Score

Get the complete analysis for MEX:INO

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN21.00
Price
MXN3.77
GF Value